US Stock MarketDetailed Quotes

PBH Prestige Consumer Healthcare

Watchlist
  • 72.560
  • -0.070-0.10%
Close Mar 28 16:00 ET
  • 72.560
  • 0.0000.00%
Post 16:20 ET
3.60BMarket Cap-45350P/E (TTM)

About Prestige Consumer Healthcare Company

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Company Profile

SymbolPBH
Company NamePrestige Consumer Healthcare
Listing Date02/10/2005
Issue Price16.00
Founded1996
CEOMr. Ronald M. Lombardi
MarketNYSE
Employees560
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address660 White Plains Road,Suite 250
CityTarrytown
ProvinceNew York
CountryUnited States of America
Zip Code10591
Phone1-914-524-6800

Company Executives

  • Name
  • Position
  • Salary
  • Ronald M. Lombardi
  • Chairman of the Board, President and Chief Executive Officer
  • 5.58M
  • Christine Sacco
  • Chief Financial Officer and Principal Accounting Officer
  • 1.96M
  • William C. P'Pool
  • Senior Vice President, General Counsel and Corporate Secretary
  • 1.29M
  • Jeffrey Zerillo
  • Executive Vice President, Operations
  • 846.92K
  • Adel Mekhail
  • Executive Vice President, Marketing and Sales
  • 1.30M
  • Christopher J. Coughlin
  • Independent Director
  • 260.00K
  • Dr. Celeste A. Clark, PhD
  • Independent Director
  • 257.01K
  • John E. Byom
  • Lead Independent Director
  • 270.00K
  • Dawn M. Zier
  • Independent Director
  • 257.50K
  • Natale S. Ricciardi
  • Independent Director
  • 240.00K
  • Sheila A. Hopkins
  • Independent Director
  • 240.00K
  • James C. D’Arecca
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg